NIH study of ME/CFS points to clear biological hallmarks

Alison Sbrana contracted infectious mononucleosis as a college student, which led to her developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This disease affects 4.3 million American adults, leading to chronic fatigue, flu-like symptoms, and changes in the brain’s functionality. However, research on ME/CFS is limited, with no current treatment available. A recent study from the National Institutes of Health identified biological markers of the condition, but only included 17 patients, limiting its scope. More studies are needed to understand the causes and treatments for ME/CFS and provide much-needed help to its patients.

Source link

error: Content is protected !!